Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 22.7 USD -3.49%
Market Cap: 1.5B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

TNDM Price Targets Summary
Tandem Diabetes Care Inc

Wall Street analysts forecast TNDM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNDM is 36.14 USD with a low forecast of 18.18 USD and a high forecast of 78.75 USD.

TNDM Lowest Forecast
Wall Street Target
18.18 USD
20% Downside
TNDM Average Forecast
Wall Street Target
36.14 USD
59% Upside
TNDM Highest Forecast
Wall Street Target
78.75 USD
247% Upside
Lowest
Price Target
18.18 USD
20% Downside
Average
Price Target
36.14 USD
59% Upside
Highest
Price Target
78.75 USD
247% Upside
Tandem Diabetes Care Inc Competitors:
Price Targets
6609
Shanghai HeartCare Medical Technology Corp Ltd
26% Downside
EMBLA
Embla Medical hf
7% Upside
BFLY
Butterfly Network Inc
90% Upside
DCTH
Delcath Systems Inc
27% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
26% Downside
EMBLA
Embla Medical hf
7% Upside
BFLY
Butterfly Network Inc
90% Upside
DCTH
Delcath Systems Inc
27% Upside
P
9996
Peijia Medical Ltd
5% Upside
METN
Metall Zug AG
2% Upside
RMD
Resmed Inc
8% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
40% Upside

Revenue
Forecast

Revenue Estimate
Tandem Diabetes Care Inc

For the last 8 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 35%. The projected CAGR for the next 3 years is 10%.

35%
Past Growth
10%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

See Also

Summary
TNDM intrinsic value, competitors valuation, and company profile.
DCF Valuation
TNDM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TNDM stock valuation using valuation multiples.
Wall Street Estimates
TNDM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TNDM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNDM's stock price target?
Price Target
36.14 USD

According to Wall Street analysts, the average 1-year price target for TNDM is 36.14 USD with a low forecast of 18.18 USD and a high forecast of 78.75 USD.

What is Tandem Diabetes Care Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 35%. The projected CAGR for the next 3 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.